Computacenter PLC
02 April 2004
Notification of Interests of Directors and Connected Persons
The following directors of Computacenter plc were, today, granted share options
under the Company's Performance Related Share Option Scheme 1998 in the amounts
and on the terms listed below.
Name Number of Exercise Price (£) Terms of Exercise Balance of
shares under shares under
option option
Mr R A Sandler 76,650 4.24 Exercisable 3 years after date 985,136
of grant
Mr M J Norris 126,768 4.24 Exercisable 3 years after date 755,823
of grant
Mr F A Conophy 79,599 4.24 Exercisable 3 years after date 315,953
of grant
In all cases the options are over the Company's ordinary 5p shares with an
exercise price of £4.24 (being the closing mid-market price on 1 April 2004) per
share option. Nil consideration was paid for the grant of these options.
Performance Criteria
Options become exercisable if the average annual compound growth in the
Company's earnings per share (on a pre-exceptional, post investment in the
Biomni joint venture, fully diluted basis) compared to the base year of 2003, is
at least equal to RPI plus 5% in any of the three, four or five year periods up
to and including 2006, 2007 or 2008, respectively
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.